Help
Subscribe


GastroHep.com - the global online resource for all aspects of gastroenterology, hepatology and endoscopy

 19 November 2017

Advanced search
GastroHep.com - the global online resource for all aspects of gastroenterology, hepatology and endoscopy Profile of Roy Pounder

Home

News  
Journals
Review Articles
Slide Atlas
Video Clips
Online Books
Advanced Digestive Endoscopy
Classical Cases
Conference Diary
PubMed
International GH Links
USA GH Links
National GH Links
National GI Societies
Other Useful Links




Emails on Gastroenterology and Hepatology
the National AIDS Treatment Advocacy Project
Visit the gastroenterology section of the EUMS

News

Routine endoscopic biopsies for H. pylori detection in non-ulcer dyspepsia

In adults with non-ulcer dyspepsia who are undergoing endoscopy, routine biopsy for the detection of H. pylori is costly, but effective, finds a research team in the July issue of Gastrointestinal Endoscopy.

News image

fiogf49gjkf04

The role of endoscopic biopsies in the detection of Helicobacter pylori in patients with non-ulcer dyspepsia is not clear.

In this study, researchers from Canada and Europe assessed the cost-effectiveness of performing routine biopsies to detect H. pylori at upper endoscopy.

The team based their clinical decision-making on outcomes data from published articles and expert opinion.

They evaluated adults (< 45 years) with non-ulcer dyspepsia defined by a normal endoscopy.

Endoscopy with biopsy and rapid urease testing costs $3940 per additional symptom-free patient.
Gastrointestinal Endoscopy

Costs, expressed in Canadian dollars, were tabulated over a 1-year time period.

The main outcome measured by the team was relief of symptoms. This was defined as the absence of symptom persistence or recurrence over the 12 months.

The researchers compared performing a biopsy for the detection of H. pylori with a rapid urease test during gastroscopy, with that of not performing a biopsy.

They also performed a secondary analysis, where they evaluated the cost-effectiveness of obtaining a biopsy specimen for histopathologic evaluation in patients after a negative rapid urease test.

The researchers found that endoscopy with biopsy and rapid urease testing costs $3940 per additional symptom-free patient, compared with endoscopy without biopsy.

However, they determined that this result was sensitive to the difference in symptomatic recurrence rate at 1 year, in patients in whom H. pylori eradication was successful and unsuccessful. The team set this rate at 10%.

Only when the difference in symptomatic recurrence in these patients fell to less than 4% was endoscopy with biopsy over $10,000 per cured patient greater than endoscopy without biopsy.

The team identified little additional benefit associated with histopathologic assessment of biopsy specimens in patients with a negative rapid urease test. Cost per additional cure was $25,529.

Dr Nicholaos Makris's team concluded, "In adults with non-ulcer dyspepsia under age 45 years undergoing endoscopy, routine procurement of a biopsy specimen for detection of H. pylori was more costly yet more effective compared with not obtaining a specimen".

"The cost-effectiveness of a biopsy is dependent on the benefits of H. pylori eradication in this patient population".

"The less likely a patient with non-ulcer dyspepsia is to become asymptomatic after successful H. pylori eradication, the more costly a strategy of routinely obtaining a specimen at endoscopy".

"The additional cost of sending a specimen for histopathologic analysis if the rapid urease test is negative does not appear warranted based on cost-effectiveness considerations".

Gastrointest Endosc 2003; 58: 14-22
04 July 2003

Go to top of page Email this page Email this page to a colleague

 17 November 2017 
Food elimination diets for treatment of adults with eosinophilic esophagitis
 17 November 2017 
PPI use and cognitive function in women
 17 November 2017 
Predicting microscopic colitis
 16 November 2017 
NAFLD-hepatocellular carcinoma and survival after orthotopic liver transplant
 16 November 2017 
Prepregnancy obesity and severe maternal morbidity
 16 November 2017 
Celiac disease screening in adult first-degree relatives
 15 November 2017 
Breastfeeding and the risk of IBD
 15 November 2017 
Medication nonadherence and health care costs
 15 November 2017 
Predicting recurrence after curative rectal cancer surgery
 14 November 2017 
HBV/HCV coinfection and cirrhosis
 14 November 2017 
Sexual dysfunction after rectal cancer surgery
 14 November 2017 
Eosinophilic gastroenteritis and colitis
 13 November 2017 
GI bleeding in patients taking non–vitamin K antagonist oral anticoagulants
 13 November 2017 
Genetic polymorphisms, fatty acids and ulcerative colitis
 13 November 2017 
Flares after immunomodulator withdrawal in Crohn's
 10 November 2017 
Thiopurines vs TNF and lymphoma risk in IBD
 10 November 2017 
Drug monitoring of anti-tumour necrosis factor therapy in IBD
 10 November 2017 
Treatment decisions for older patients with colorectal cancer
 09 November 2017 
Quality standards in upper gastrointestinal endoscopy
 09 November 2017 
Irradiated rectal cancer and chemoradiotherapy
 09 November 2017 
Environmental factors and IBD
 08 November 2017 
Prophylaxis of spontaneous bacterial peritonitis
 08 November 2017 
Socioeconomic characteristics in diverticular disease
 08 November 2017 
Optimal management of postoperative Crohn's disease
 07 November 2017 
Community Screening for Helicobacter pylori
 07 November 2017 
Early readmission in IBD patients
 07 November 2017 
Mesocolic excision for colon cancer
 06 November 2017 
Food elimination diet for children with eosinophilic esophagitis
 06 November 2017 
Biologic agents and obesity in children with IBD
 06 November 2017 
Liver cancer burden despite extensive use of antiviral agents
 03 November 2017 
Statins and mortality in chronic viral hepatitis
 03 November 2017 
Propofol for outpatient colonoscopy
 03 November 2017 
Asthma and IBD development
 02 November 2017 
Diverticulitis and emergency department burden
 02 November 2017 
Rural residence and risk of IBD
 02 November 2017 
Sexual functioning in Hep C
 01 November 2017 
Heartburn relief in adolescents with GERD
 01 November 2017 
Barriers to hepatitis C treatment
 01 November 2017 
Autoimmune pancreatitis in children
 31 October 2017 
Surveillance in ulcerative colitis and Crohn’s disease
 31 October 2017 
Endoscopic indices of disease activity for Crohn’s
 31 October 2017 
Follow-up of positive results on fecal blood tests
 30 October 2017 
Local recurrence after curative rectal cancer surgery
 30 October 2017 
Low-flow ascites pump in refractory cirrhosis
 30 October 2017 
Medical therapy of patients with pediatric-onset IBD
 27 October 2017 
NAFLD in advanced fibrosis in the USA
 27 October 2017 
Early readmission in cirrhosis after bacterial infections
 26 October 2017 
Predicting response to anti-TNF therapy in Crohn's
 26 October 2017 
Conversion to open laparotomy in rectal cancer
 25 October 2017 
Conversion of colonoscopy to sigmoidoscopy
 25 October 2017 
Fecal microbiota transplantation
 25 October 2017 
Rifaximin and survival in hepatic encephalopathy
 24 October 2017 
Eosinophilic esophagitis with swallowed topical corticosteroids
 24 October 2017 
Meta-analysis in nutritiona research
 23 October 2017 
NAFLD-related hepatocellular carcinoma in liver resection
 23 October 2017 
Outcome of hepatic sarcoidosis
 20 October 2017 
Hospital readmissions reduction program
 20 October 2017 
Conversion of planned colonoscopy to sigmoidoscopy
 19 October 2017 
Fecal immunochemical tests in colorectal cancer screening
 19 October 2017 
Current management of chylous ascites

Blackwell Publishing


GastroHep.com is a Blackwell Publishing registered trademark
© 2017 Wiley-Blackwell and GastroHep.com and contributors
Privacy Statement
Disclaimer
About Us